Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP. [electronic resource]
Producer: 20080418Description: 322-33 p. digitalISSN:- 0263-6352
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Animals
- Antihypertensive Agents -- pharmacology
- Blood Pressure -- drug effects
- Drug Therapy, Combination
- Endomyocardial Fibrosis -- drug therapy
- Endothelium, Vascular -- drug effects
- Hydralazine -- pharmacology
- Hypertension -- drug therapy
- Male
- Mesenteric Arteries -- drug effects
- Neprilysin -- antagonists & inhibitors
- Rats
- Rats, Inbred SHR
- Rats, Wistar
- Stroke -- etiology
- Tetrazoles -- pharmacology
- Tyrosine -- analogs & derivatives
- Valine -- analogs & derivatives
- Valsartan
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.